Data From Chinese City Shows Higher Proportion of COVID-19 Infection Among Those Vaccinated With Chinese-Made Vaccines

Data From Chinese City Shows Higher Proportion of COVID-19 Infection Among Those Vaccinated With Chinese-Made Vaccines
People line up for nucleic acid testing during a citywide mass testing for the Covid-19 in Tianjin, China January 9, 2022. (cnsphoto via Reuters)

The Chinese regime’s data from one new affected area of COVID-19 outbreaks in mainland China show a much higher rate of vaccination rate among the infected patients.

The data published by Yuzhou city in Henan Province shows the same trait. According to the data announced by local authorities, the vaccination rate of the infected people in Yuzhou is 92 percent. As reported by the regime’s media China News Service, in Henan, a total of 141 million doses of COVID-19 vaccines had been administered and 64.61 million people had been fully vaccinated.

According to China’s most recent seventh national census, as of November 2020, Henan’s population is 99.366 million. Based on the data, the overall vaccination rate in Henan Province is about 65 percent. The vaccination rate of infected people in Yuzhou is nearly 27 percentage points higher than this figure.

The Chinese communist regime only provides the Chinese people with domestically produced COVID-19 vaccines, including two doses of inactivated vaccines from Chinese companies such as Sinopharm or Sinovac, or one dose of adenovirus vector vaccine (Ad5-nCoV) from Tianjin CanSinoBio.

In this new round of COVID-19 outbreak this year in China, the Omicron variant was detected in Tianjin city, confirmed virus cases in Yuzhou City were of the Delta variant.

Judging from the breakthrough cases of Omicron, Delta, and other variant viruses, and the higher vaccination rate of infected people in Tianjin and Yuzhou far exceeds that of uninfected people in the same areas, Li Longteng, the former deputy director of Taiwan’s Department of Health, told Chinese edition of The Epoch Times, “This shows that the Chinese made COVID-19 vaccine are ineffective. At most, it will produce a little antibody and reduce some serious symptoms or death.”

The two major Chinese COVID-19 vaccines: Sinovac and Sinopharm have been approved by the World Health Organization (WHO) for emergency approval and are widely used in lower-income countries.

Long Tengyun contributed to the report.
A previous version of this article misstated the vaccination rate in Tianjin City. The Epoch Times regrets this error. 
Alex Wu is a U.S.-based writer for The Epoch Times focusing on Chinese society, Chinese culture, human rights, and international relations.
Related Topics